In the News

This article summarises ICON’s quarterly and 2021 year-end financial results.

This article shares how the medical and biotech sectors have dominated the mergers & acquisitions (M&A) landscape and mentions ICON’s acquisition of PRA Health Sciences.

This article provides an overview of the mergers and acquisition activity that took place in Ireland across 2021. This includes ICON’s $12bn acquisition of PRA Health Sciences as one of the “big deals of 2021”.

In this two-part series, Emily Mitchell and Kathleen Mandziuk offer their insights on the evolution of data technology.

A series of interviews in celebration of Black History Month, featuring members of the Black community who work within the field of STEM, as we want to allow more diverse voices to be heard and acknowledge their achievements.

Brian Huber considers the affordability, access and reimbursement challenges within the gene therapy market.

This article considers how partnering with a CRO can help emerging biotechs to secure funding.

In this snapshot from the J.P. Morgan Healthcare Conference, Steve Cutler comments on ICON’s success in decentralised trials and therapeutic technologies such as mRNA and checkpoint inhibitors.

This article discusses ICON’s forecast revenues for 2022 and includes a statement from Steve Cutler on ICON’s successes from 2021.

Cindy Spittle shares insights on the growth of molecular diagnostic testing in clinical trials.